Durability of Antibody Response after Primary Pneumococcal Double-Dose Prime-Boost Vaccination in Adult Kidney Transplant Recipients and Candidates: 18-Month Follow-Up in a Non-Blinded, Randomised Clinical Trial.

Pelle Trier Petersen Claus Bistrup Søren Schwartz Sørensen Lene Boesby Charlotte Sværke Jørgensen Christian Nielsen Isik Somuncu Johansen

Published in: Vaccines (2022)

At follow-up, the pneumococcal prime-boost vaccination still provided significantly elevated average pneumococcal AB GMCs in both populations. Though the proportion of participants protected against IPD in WLP-DD and WLP-ND were statistically comparable, a DD may still be recommended for WLPs (EudraCT: 2016-004123-23).

Keyphrases

clinical trial
study protocol
open label
double blind
placebo controlled
randomized controlled trial
phase iii